Operating Lease, Right-of-Use Asset of ARROWHEAD PHARMACEUTICALS, INC. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ARROWHEAD PHARMACEUTICALS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • ARROWHEAD PHARMACEUTICALS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $43,361,000, a 3.4% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ARROWHEAD PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $43,361,000 -$1,508,000 -3.4% 31 Dec 2025 10-Q 05 Feb 2026 2026 Q1
Q3 2025 $43,891,000 -$1,364,000 -3% 30 Sep 2025 10-Q 05 Feb 2026 2026 Q1
Q2 2025 $44,002,000 -$337,000 -0.76% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q3
Q1 2025 $44,452,000 -$174,000 -0.39% 31 Mar 2025 10-Q 12 May 2025 2025 Q2
Q4 2024 $44,869,000 -$38,000 -0.08% 31 Dec 2024 10-Q 10 Feb 2025 2025 Q1
Q3 2024 $45,255,000 -$42,000 -0.09% 30 Sep 2024 10-K 25 Nov 2025 2025 FY
Q2 2024 $44,339,000 +$3,672,000 +9% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q3
Q1 2024 $44,626,000 +$3,512,000 +8.5% 31 Mar 2024 10-Q 09 May 2024 2024 Q2
Q4 2023 $44,907,000 +$3,252,000 +7.8% 31 Dec 2023 10-Q 06 Feb 2024 2024 Q1
Q3 2023 $45,297,000 -$12,994,000 -22% 30 Sep 2023 10-K 26 Nov 2024 2024 FY
Q2 2023 $40,667,000 -$28,241,000 -41% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q3
Q1 2023 $41,114,000 +$24,735,000 +151% 31 Mar 2023 10-Q 02 May 2023 2023 Q2
Q4 2022 $41,655,000 +$24,780,000 +147% 31 Dec 2022 10-Q 06 Feb 2023 2023 Q1
Q3 2022 $58,291,000 +$40,945,000 +236% 30 Sep 2022 10-K 29 Nov 2023 2023 FY
Q2 2022 $68,908,000 +$50,458,000 +273% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q3
Q1 2022 $16,379,000 -$1,991,000 -11% 31 Mar 2022 10-Q 10 May 2022 2022 Q2
Q4 2021 $16,875,000 +$1,128,000 +7.2% 31 Dec 2021 10-Q 02 Feb 2022 2022 Q1
Q3 2021 $17,346,000 +$1,209,000 +7.5% 30 Sep 2021 10-K 28 Nov 2022 2022 FY
Q2 2021 $18,450,000 +$1,927,987 +12% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q3
Q1 2021 $18,370,000 +$8,106,803 +79% 31 Mar 2021 10-Q 04 May 2021 2021 Q2
Q4 2020 $15,747,000 +$5,306,242 +51% 31 Dec 2020 10-Q 04 Feb 2021 2021 Q1
Q3 2020 $16,137,000 30 Sep 2020 10-K 22 Nov 2021 2021 FY
Q2 2020 $16,522,013 30 Jun 2020 10-Q 05 Aug 2020 2020 Q3
Q1 2020 $10,263,197 31 Mar 2020 10-Q 07 May 2020 2020 Q2
Q4 2019 $10,440,758 31 Dec 2019 10-Q 05 Feb 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.